Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock

Journal of Trauma and Acute Care Surgery

Volumn 77, Issue 6, 2014, Pages 926-933

  Wang, Hao ^a   Guan, Yuxia ^b,c   Widlund, Anne Lykkegaard ^b,d   Becker, Lance B ^c   Baur, Joseph A ^b   Reilly, Patrick M ^b   Sims, Carrie A ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ROSKILDE UNIVERSITY   (Denmark)

Author keywords

Blood glucose; Hemorrhagic shock; Mitochondria; Rats; Resveratrol

Indexed keywords

BICARBONATE; CORTICOSTERONE; CYTOKINE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; RESVERATROL; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL FUNCTION; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLUID RESUSCITATION; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMORRHAGIC SHOCK; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY PARENCHYMA; LACTIC ACIDOSIS; LIVER; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; RAT; RESUSCITATION; RISK FACTOR; SUPPLEMENTATION; ANALYSIS; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; LIVER MITOCHONDRION; LONG EVANS RAT; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SHOCK, HEMORRHAGIC;

ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; KIDNEY; MALE; MITOCHONDRIA; MITOCHONDRIA, LIVER; RATS, LONG-EVANS; REACTIVE OXYGEN SPECIES; RESUSCITATION; SHOCK, HEMORRHAGIC; STILBENES;

EID: 84918524934     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000358     Document Type: Conference Paper

References (40)

1. Minei JP, Cuschieri J, Sperry J, Moore EE, West MA, Harbrecht BG, O'Keefe GE, Cohen MJ, Moldawer LL, Tompkins RG, et al. The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med. 2012;40:1129-1135.
2. Tsukamoto T, Chanthaphavong RS, Pape HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury. 2010; 41:21-26.
3. Kozlov AV, Bahrami S, Calzia E, Dungel P, Gille L, Kuznetsov AV, Troppmair J. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure? Ann Intensive Care. 2011;1:41.
4. Karamercan MA,Weiss SL, Villarroel JP, Guan Y,Werlin E, Figueredo R, Becker LB, Sims C. Can peripheral blood mononuclear cells be used as a proxy for mitochondrial dysfunction in vital organs during hemorrhagic shock and resuscitation? Shock. 2013;40:476-484.
5. Hubbard WJ, Bland KI, Chaudry IH. The role of the mitochondrion in trauma and shock. Shock. 2004;22:395-402.
6. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135-159.
7. Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion. 2004;4:729-741.
8. Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab. 2010;21:589-598.
9. Zhai L, Ballinger SW, Messina JL. Role of reactive oxygen species in injury-induced insulin resistance. Mol Endocrinol. 2011;25:492-502.
10. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004; 56:1058-1062.
11. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109-1122.
12. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
13. Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-Activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010;59:554-563.
14. Jian B, Yang S, Chaudry IH, Raju R. Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol Med. 2012;18:209-214.
15. Yu HP, Hwang TL, Yen CH, Lau YT. Resveratrol prevents endothelial dysfunction and aortic superoxide production after trauma hemorrhage through estrogen receptor-dependent hemeoxygenase-1 pathway. Crit Care Med. 2010;38:1147-1154.
16. Yu HP, Yang SC, Lau YT, Hwang TL. Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Surgery. 2010;148:103-109.
17. Yu HP, Hwang TL, Hsieh PW, Lau YT. Role of estrogen receptordependent upregulation of P38 MAPK/heme oxygenase 1 in resveratrolmediated attenuation of intestinal injury after trauma-hemorrhage. Shock. 2011;35:517-523.
18. Souba W, Wilmore D. Shock models: hemorrhage. In: Ayala A, Wang P, Chaudry I, eds. Surgical Research. San Diego, CA: Academic Press; 2001:325-327.
19. Tsai YF, Liu FC, Lau YT, Yu HP. Role of Akt-dependent pathway in resveratrol-mediated cardioprotection after trauma-hemorrhage. J Surg Res. 2012;176:171-177.
20. Palmeira CM, Moreno AJ. High-resolution respirometry. OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. In: Pesta D, Gnaiger E, eds. Mitochondrial Bioenergetics: Methods and Protocols. New York, NY: Humana Press; 2012:25-28.
21. Zhou L, Podolsky N, Sang Z, Ding Y, Fan X, Tong Q, Levin BE, McCrimmon RJ. The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia. Diabetes. 2010;59:2646-2652.
22. Jiang Y, Wu GH, Zhang B, Han -S, Zhuang QL. Acute insulin resistance following surgical trauma in rats. Exp Clin Endocrinol Diabetes. 2012; 120:315-322.
23. Ungvari Z, Sonntag WE, de Cabo R, Baur JA, Csiszar A. Mitochondrial protection by resveratrol. Exerc Sport Sci Rev. 2011;39:128-132.
24. Aksu U, Bezemer R, Yavuz B, Kandil A, Demirci C, Ince C. Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation. 2012;83:767-773.
25. Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem. 2012; 287:27255-27264.
26. Leadsham JE, Sanders G, Giannaki S, Bastow EL, Hutton R, Naeimi WR, Breitenbach M, Gourlay CW. Loss of cytochrome c oxidase promotes RAS-dependent ROS production from the ER resident NADPH oxidase, Yno1p, in yeast. Cell Metab. 2013;18:279-286.
27. Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab. 2009;20:429-435.
28. Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E. Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res Clin Pract. 2007;77(Suppl 1):S41-S45.
29. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401-414.
30. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005; 87:99-109.
31. Dao TM,Waget A, Klopp P, Serino M, Vachoux C, Pechere L, Drucker DJ, Champion S, Barthelemy S, Barra Y, et al. Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One. 2011;6:e20700.
32. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824-830.
33. Luque MA, Gonzalez N, Marquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Penacarrillo ML. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. J Endocrinol. 2002;173: 465-473.
34. Sandhu H, Wiesenthal SR, MacDonald PE, McCall RH, Tchipashvili V, Rashid S, Satkunarajah M, Irwin DM, Shi ZQ, Brubaker PL, et al. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes. 1999;48:1045-1053.
35. Gao H,Wang X, Zhang Z, Yang Y, Yang J, Li X, Ning G. GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine. 2007;32:90-95.
36. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH, Messina JL. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-Alpha. Endocrinology. 2004;145:5168-5176.
37. Xu J, Kim HT, Ma Y, Zhao L, Zhai L, Kokorina N, Wang P, Messina JL. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-Alpha. Endocrinology. 2008;149: 2369-2382.
38. Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol. 2010;224:423-432.
39. Szkudelski T, Szkudelska K. Anti-diabetic effects of resveratrol. Ann N Y Acad Sci. 2011;1215:34-39.
40. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes. 2005;54:1914-1925.